<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Twelve patients with active <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's <z:hpo ids='HP_0000554'>uveitis</z:hpo> with marked deterioration of visual acuity in at least <z:mp ids='MP_0005163'>one eye</z:mp> were treated with <z:chebi fb="0" ids="4031">cyclosporin A</z:chebi> (CyA) </plain></SENT>
<SENT sid="1" pm="."><plain>An initial improvement in the severity of <z:hpo ids='HP_0100533'>ocular inflammation</z:hpo> and systemic features occurred in <z:hpo ids='HP_0000001'>all</z:hpo> cases and persisted until the dose was reduced or the drug withdrawn when a rapid recurrence of symptoms was noted </plain></SENT>
<SENT sid="2" pm="."><plain>The visual acuity also initially improved in ten patients and this was maintained in seven cases until the dose of CyA was reduced </plain></SENT>
<SENT sid="3" pm="."><plain>At this time, acuity was unchanged in two patients and was worse in three others-two of the latter as a result of vitreous haemorrhage in the absence of active <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Seven of the 12 patients had therapy stopped because of complications; severe malaise and <z:hpo ids='HP_0002018'>nausea</z:hpo> (three cases), <z:hpo ids='HP_0000082'>decreased renal function</z:hpo> (three cases), and <z:hpo ids='HP_0000618'>blindness</z:hpo> (one case) </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="4031">Cyclosporin A</z:chebi> is of value in the control of <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's <z:hpo ids='HP_0000554'>uveitis</z:hpo> but toxicity limits its use and the benefits only last while the patient is on this therapy </plain></SENT>
</text></document>